About Anthem Biosciences
Anthem Biosciences is a company based in Bengaluru (India) founded in 2007 by Ravindra K C, Ganesh Sambashivam, and Ajay Bharadwaj.. Anthem Biosciences has raised $35.74 million across 4 funding rounds from investors including Department of Biotechnology, True North and Portsmouth Technologies Trials Unit. The company has 1,820 employees as of March 31, 2023. Anthem Biosciences offers products and services including Chemistry Services, Biology Services, and Biologics Services. Anthem Biosciences operates in a competitive market with competitors including Abzena, Patheon, Syngene, Piramal Group and Panacea Biotec, among others.
- Headquarter Bengaluru, India
- Employees 1820 as on 31 Mar, 2023
- Founders Ravindra K C, Ganesh Sambashivam, Ajay Bharadwaj
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Anthem Biosciences Limited
-
Annual Revenue
$170.19 M (USD)34.29as on Mar 31, 2024
-
Net Profit
$44.02 M (USD)-4.64as on Mar 31, 2024
-
EBITDA
$61.77 M (USD)18.3as on Mar 31, 2024
-
Total Equity Funding
$35.74 M (USD)
in 4 rounds
-
Latest Funding Round
$33.41 M (USD), Series A
Mar 01, 2021
-
Investors
Department of Biotechnology
& 3 more
-
Employee Count
1820
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Anthem Biosciences
Anthem Biosciences is a publicly listed company on the NSE with ticker symbol ANTHEM in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Anthem Biosciences
Anthem Biosciences offers a comprehensive portfolio of products and services, including Chemistry Services, Biology Services, and Biologics Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides chemical discovery and development for life sciences applications.
Offers gene design and biologics manufacturing for health innovations.
Delivers biologics production with quality and compliance focus.
Unlock access to complete
Unlock access to complete
Funding Insights of Anthem Biosciences
Anthem Biosciences has successfully raised a total of $35.74M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $33.41 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $33.4M
-
First Round
First Round
(29 May 2008)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Series A - Anthem Biosciences | Valuation | True North |
|
| Nov, 2016 | Amount | Seed - Anthem Biosciences | Valuation | Portsmouthtechnologiestrialsunit |
|
| Jun, 2012 | Amount | Grant - Anthem Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Anthem Biosciences
Anthem Biosciences has secured backing from 4 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Department of Biotechnology, True North and Portsmouth Technologies Trials Unit. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity is invested by True North in mid-market companies.
|
Founded Year | Domain | Location | |
|
Research in healthcare technologies is supported by this unit.
|
Founded Year | Domain | Location | |
|
Biotechnology research, guidelines, and funding by the Government of India.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Anthem Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Anthem Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Anthem Biosciences Comparisons
Competitors of Anthem Biosciences
Anthem Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abzena, Patheon, Syngene, Piramal Group and Panacea Biotec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of antibody discovery, cell line development, and bio analytics services
|
|
| domain | founded_year | HQ Location |
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
|
|
| domain | founded_year | HQ Location |
Provider of contract research and manufacturing services for both small molecules and biologics
|
|
| domain | founded_year | HQ Location |
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
|
| domain | founded_year | HQ Location |
Developer of biosimilars, vaccines and natural products
|
|
| domain | founded_year | HQ Location |
Provides enabling tools and services in the life sciences research and bio-production industries
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Anthem Biosciences
Frequently Asked Questions about Anthem Biosciences
When was Anthem Biosciences founded?
Anthem Biosciences was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is Anthem Biosciences located?
Anthem Biosciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Who is the current CEO of Anthem Biosciences?
Ajay Bharadwaj is the current CEO of Anthem Biosciences. They have also founded this company.
Is Anthem Biosciences a funded company?
Anthem Biosciences is a funded company, having raised a total of $35.74M across 4 funding rounds to date.
How many employees does Anthem Biosciences have?
As of Mar 31, 2023, the latest employee count at Anthem Biosciences is 1,820.
What is the annual revenue of Anthem Biosciences?
Annual revenue of Anthem Biosciences is $170.19M as on Mar 31, 2024.
What does Anthem Biosciences do?
Developer of integrated contract research development and manufacturing services. The company offers endtoend drug discovery, development and manufacturing support for small molecules, biologics and nutritional actives. It provides medicinal chemistry, process synthesis, analytical RD, toxicology and GLP preclinical testing under one roof. Services include microbial screening, protein expression, peptide synthesis, antibody drug conjugates and fermentation scaleup capable from milligram to tonne volumes. The infrastructure includes cGMP kilolabs, pilot manufacturing and AAALAC accredited vivarium for in vitro and in vivo studies. Quality control, regulatory compliance and analytical method development are embedded as part of the scientific service portfolio.
Who are the top competitors of Anthem Biosciences?
Anthem Biosciences's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.
What products or services does Anthem Biosciences offer?
Anthem Biosciences offers Chemistry Services, Biology Services, and Biologics Services.
Is Anthem Biosciences publicly traded?
Yes, Anthem Biosciences is publicly traded on NSE under the ticker symbol ANTHEM.
Who are Anthem Biosciences's investors?
Anthem Biosciences has 4 investors. Key investors include Department of Biotechnology, True North, Portsmouth Technologies Trials Unit, and Muppala Raju.
What is Anthem Biosciences's ticker symbol?
The ticker symbol of Anthem Biosciences is ANTHEM on NSE.
What is Anthem Biosciences's valuation?
The valuation of Anthem Biosciences is $999.08M as of Mar 2021.